Table 1. Ophthalmic Disease Therapeutic Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Ophthalmic Disease Therapeutic Market Restraints

Table 3. Ophthalmic Disease Therapeutic Market Trends

Table 4. Ophthalmic Disease Therapeutic Industry Policy

Table 5. Global Ophthalmic Disease Therapeutic Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Ophthalmic Disease Therapeutic Revenue Market Share by Company (2018-2023)

Table 7. Global Ophthalmic Disease Therapeutic Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Ophthalmic Disease Therapeutic Mergers & Acquisitions, Expansion Plans

Table 9. Global Ophthalmic Disease Therapeutic Manufacturers Product Type

Table 10. China Ophthalmic Disease Therapeutic Revenue by Company (2018-2023) & (US$ million)

Table 11. China Ophthalmic Disease Therapeutic Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Ophthalmic Disease Therapeutic Upstream (Raw Materials)

Table 13. Global Ophthalmic Disease Therapeutic Typical Customers

Table 14. Ophthalmic Disease Therapeutic Typical Distributors

Table 15. By Type, Global Ophthalmic Disease Therapeutic Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Ophthalmic Disease Therapeutic Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Ophthalmic Disease Therapeutic Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Ophthalmic Disease Therapeutic Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Ophthalmic Disease Therapeutic Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Ophthalmic Disease Therapeutic Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Ophthalmic Disease Therapeutic Revenue Market Share, 2018-2029

Table 22. Regeneron Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 23. Regeneron Pharmaceuticals Company Profile and Main Business

Table 24. Regeneron Pharmaceuticals Ophthalmic Disease Therapeutic Models, Specifications and Application

Table 25. Regeneron Pharmaceuticals Ophthalmic Disease Therapeutic Revenue and Gross Margin, 2018-2023

Table 26. Regeneron Pharmaceuticals Recent Developments

Table 27. AbbVie Inc Company Information, Head Office, Market Area and Industry Position

Table 28. AbbVie Inc Company Profile and Main Business

Table 29. AbbVie Inc Ophthalmic Disease Therapeutic Models, Specifications and Application

Table 30. AbbVie Inc Ophthalmic Disease Therapeutic Revenue and Gross Margin, 2018-2023

Table 31. AbbVie Inc Recent Developments

Table 32. Santen Pharmaceutical Co. Ltd. Company Information, Head Office, Market Area and Industry Position

Table 33. Santen Pharmaceutical Co. Ltd. Company Profile and Main Business

Table 34. Santen Pharmaceutical Co. Ltd. Ophthalmic Disease Therapeutic Models, Specifications and Application

Table 35. Santen Pharmaceutical Co. Ltd. Ophthalmic Disease Therapeutic Revenue and Gross Margin, 2018-2023

Table 36. Santen Pharmaceutical Co. Ltd. Recent Developments

Table 37. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 38. Novartis AG Company Profile and Main Business

Table 39. Novartis AG Ophthalmic Disease Therapeutic Models, Specifications and Application

Table 40. Novartis AG Ophthalmic Disease Therapeutic Revenue and Gross Margin, 2018-2023

Table 41. Novartis AG Recent Developments

Table 42. Bayer AG Company Information, Head Office, Market Area and Industry Position

Table 43. Bayer AG Company Profile and Main Business

Table 44. Bayer AG Ophthalmic Disease Therapeutic Models, Specifications and Application

Table 45. Bayer AG Ophthalmic Disease Therapeutic Revenue and Gross Margin, 2018-2023

Table 46. Bayer AG Recent Developments

Table 47. F. Hoffmann-La Roche Company Information, Head Office, Market Area and Industry Position

Table 48. F. Hoffmann-La Roche Company Profile and Main Business

Table 49. F. Hoffmann-La Roche Ophthalmic Disease Therapeutic Models, Specifications and Application

Table 50. F. Hoffmann-La Roche Ophthalmic Disease Therapeutic Revenue and Gross Margin, 2018-2023

Table 51. F. Hoffmann-La Roche Recent Developments

Table 52. Viatris Inc. Company Information, Head Office, Market Area and Industry Position

Table 53. Viatris Inc. Company Profile and Main Business

Table 54. Viatris Inc. Ophthalmic Disease Therapeutic Models, Specifications and Application

Table 55. Viatris Inc. Ophthalmic Disease Therapeutic Revenue and Gross Margin, 2018-2023

Table 56. Viatris Inc. Recent Developments

List of Figure

Figure 1. Ophthalmic Disease Therapeutic Picture

Figure 2. Global Ophthalmic Disease Therapeutic Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Ophthalmic Disease Therapeutic Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Ophthalmic Disease Therapeutic Market Share of Global

Figure 5. Global Ophthalmic Disease Therapeutic Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Ophthalmic Disease Therapeutic Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Ophthalmic Disease Therapeutic Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Ophthalmic Disease Therapeutic Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Ophthalmic Disease Therapeutic Industry Chain

Figure 10. Anti-inflammatory

Figure 11. Anti-infectives

Figure 12. Anti-VEGF

Figure 13. Anti-glaucoma

Figure 14. By Type, Global Ophthalmic Disease Therapeutic Revenue, 2018-2029, US$ Million

Figure 15. By Type, Global Ophthalmic Disease Therapeutic Revenue Market Share, 2018-2029

Figure 16. Glaucoma

Figure 17. Dry Eye Disease

Figure 18. Retinal Diseases

Figure 19. Allergy & Infections

Figure 20. By Application, Global Ophthalmic Disease Therapeutic Revenue, 2018-2029, US$ Million

Figure 21. By Application, Global Ophthalmic Disease Therapeutic Revenue Market Share, 2018-2029

Figure 22. By Region, Global Ophthalmic Disease Therapeutic Revenue Market Share, 2018-2029

Figure 23. North America Ophthalmic Disease Therapeutic Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, North America Ophthalmic Disease Therapeutic Revenue Market Share, 2018-2023

Figure 25. Europe Ophthalmic Disease Therapeutic Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country, Europe Ophthalmic Disease Therapeutic Revenue Market Share, 2018-2023

Figure 27. Asia Pacific Ophthalmic Disease Therapeutic Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country/Region, Asia Pacific Ophthalmic Disease Therapeutic Revenue Market Share, 2018-2023

Figure 29. South America Ophthalmic Disease Therapeutic Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. By Country, South America Ophthalmic Disease Therapeutic Revenue Market Share, 2018-2023

Figure 31. Middle East & Africa Ophthalmic Disease Therapeutic Revenue & Forecasts, 2018-2029, US$ Million

Figure 32. U.S. Ophthalmic Disease Therapeutic Revenue, 2018-2029, (US$ Million)

Figure 33. By Company, U.S. Ophthalmic Disease Therapeutic Market Share, 2018-2023

Figure 34. By Type, U.S. Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 35. By Application, U.S. Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 36. Europe Ophthalmic Disease Therapeutic Revenue, 2018-2029, (US$ Million)

Figure 37. By Company, Europe Ophthalmic Disease Therapeutic Market Share, 2018-2023

Figure 38. By Type, Europe Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 39. By Application, Europe Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 40. China Ophthalmic Disease Therapeutic Revenue, 2018-2029, (US$ Million)

Figure 41. By Company, China Ophthalmic Disease Therapeutic Market Share, 2018-2023

Figure 42. By Type, China Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 43. By Application, China Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 44. Japan Ophthalmic Disease Therapeutic Revenue, 2018-2029, (US$ Million)

Figure 45. By Company, Japan Ophthalmic Disease Therapeutic Market Share, 2018-2023

Figure 46. By Type, Japan Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 47. By Application, Japan Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 48. South Korea Ophthalmic Disease Therapeutic Revenue, 2018-2029, (US$ Million)

Figure 49. By Company, South Korea Ophthalmic Disease Therapeutic Market Share, 2018-2023

Figure 50. By Type, South Korea Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 51. By Application, South Korea Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 52. Southeast Asia Ophthalmic Disease Therapeutic Revenue, 2018-2029, (US$ Million)

Figure 53. By Company, Southeast Asia Ophthalmic Disease Therapeutic Market Share, 2018-2023

Figure 54. By Type, Southeast Asia Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 55. By Application, Southeast Asia Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 56. India Ophthalmic Disease Therapeutic Revenue, 2018-2029, (US$ Million)

Figure 57. By Company, India Ophthalmic Disease Therapeutic Market Share, 2018-2023

Figure 58. By Type, India Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 59. By Application, India Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 60. Middle East & Asia Ophthalmic Disease Therapeutic Revenue, 2018-2029, (US$ Million)

Figure 61. By Company, Middle East & Asia Ophthalmic Disease Therapeutic Market Share, 2018-2023

Figure 62. By Type, Middle East & Asia Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 63. By Application, Middle East & Asia Ophthalmic Disease Therapeutic Revenue Market Share, 2022 VS 2029

Figure 64. Research Methodology

Figure 65. Breakdown of Primary Interviews

Figure 66. Bottom-up Approaches

Figure 67. Top-down Approaches